Pressemitteilungen zu dem Thema pressure biosciences


Unterkategorien

PresseMitteilungen zu dem Schlagwort pressure biosciences


Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/14/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments and related consumables to the worldwide life sciences industry, today announced financial results for the third quarter of 2017, provided a business update, and offered limited guidance on its expected revenue for remainder of FY 2017.Mr. Joseph L. Damasio, Jr., VP of Finance ...


14.11.2017

Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/13/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company''s website).The teleconferenc ...


13.11.2017

Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China

SOUTH EASTON, MA -- (Marketwired) -- 11/01/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, today announced that Professor Tiannan Guo''s laboratory at Westlake Institute for Advanced Study ("WIAS") has been named the Company''s first Center of Excellence (&quo ...


01.11.2017

Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions

SOUTH EASTON, MA -- (Marketwired) -- 10/18/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, today announced a collaboration with Phasex Corporation, one the world''s most experienced supercritical fluid ("SCF")-based toll processors. Since 1981, Phasex has been a leader in the development of cutt ...


18.10.2017

Pressure BioSciences'' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

SOUTH EASTON, MA -- (Marketwired) -- 09/18/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company''s next-generation PCT instrument -- the Barocycler 2320EXTREME (the "Barocycler 2320EXT") -- has been selected as a Finalist in ...


18.09.2017

Pressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017

SOUTH EASTON, MA -- (Marketwired) -- 09/11/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at the 19th Annual Rodman & Renshaw Global Investment Conference.Mr. Schumach ...


11.09.2017

Pressure BioSciences, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 08/16/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced financial results for the second quarter of 2017, provided a business update, and offered limited guidance on its growth plan for FY2017.Total revenue for the 2017 sec ...


16.08.2017

Pressure BioSciences, Inc. to Discuss Second Quarter 2017 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 08/15/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Second Quarter 2017 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay approximately one day after the call (by telephone or via a link on the Company''s website).The teleconferen ...


15.08.2017

Pressure BioSciences'' Barocycler 2320EXTREME to be Featured in Multiple Presentations All Week at Major Scientific Meeting

SOUTH EASTON, MA -- (Marketwired) -- 06/06/17 -- Pressure BioSciences, Inc. (OTCQB: PBIOD) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company''s patented PCT platform will be featured in multiple presentations at the annual conference of the American Society for Mass Spectrometry ...


06.06.2017

Dr. Ruedi Aebersold Receives the Prestigious Karger Medal Recognizing an Individual Who Has Significantly Contributed to the Development of New Bioanalytical Methods

SOUTH EASTON, MA -- (Marketwired) -- 06/05/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Dr. Ruedi Aebersold recently received the prestigious Karger Medal from the Barnett Institute of Chemical & Biological Analysis at Northeastern University in ...


05.06.2017

Pressure BioSciences, Inc. Announces One-for-Thirty Reverse Stock Split

SOUTH EASTON, MA -- (Marketwired) -- 06/02/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company''s outstanding convertible securities will also be adjusted accordingly.The reverse stock split is intended to increase the per share trading price of the Company''s common stock to satisfy the $4.00 minim ...


02.06.2017

Pressure BioSciences, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 05/16/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced financial results for the first quarter of 2017, provided a business update, and offered limited guidance on its growth plan for FY2017.Products and services revenue i ...


16.05.2017

Pressure BioSciences, Inc. Appoints Joseph L. Damasio Jr. as Vice President of Finance and Chief Financial Officer

SOUTH EASTON, MA -- (Marketwired) -- 04/17/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Joseph L. Damasio Jr. joined the Company as its Vice President of Finance and Chief Financial Officer ("CFO") on April 10, 2017.Mr. Damasio has over ...


17.04.2017

Pressure BioSciences, Inc. Significantly Expands Marketing and Sales Capabilities

SOUTH EASTON, MA -- (Marketwired) -- 03/23/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that it has significantly bolstered its marketing and sales capabilities by contracting with well-known and highly regarded EKG Sales Associates, and by hiring two of ...


23.03.2017

Pressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 03/22/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2016, provided a business update, and offered limited guidance for FY2017.Products and services revenue was $365,262 in the fourth quarter of 2016 compared to $235,600 in the same quarter of 2015, a 55% increase. Sales of consumables were $50,054 for the fourth quarter en ...


22.03.2017

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2016 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 03/21/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2016 financial results and to provide a business update. Anyone interested may listen to the teleconference by telephone (live) or through a replay by telephone or on the Company''s website.The teleconference will include a Company presentation fo ...


21.03.2017

Pressure BioSciences Receives 2017 North American Excellence Award: "Best New Instrument for Sample Preparation"

SOUTH EASTON, MA -- (Marketwired) -- 03/01/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that its Barocycler 2320EXTREME ("2320EXT") has been named the "Best New Instrument for Sample Preparation 2017" by Corporate America News (" ...


01.03.2017

Pressure BioSciences Achieves CE Marking for its Next Generation Sample Preparation Instrument, the Barocycler 2320EXTREME

SOUTH EASTON, MA -- (Marketwired) -- 02/02/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that the Company has achieved CE Marking for the Barocycler 2320EXTREME ("2320EXT"), the Company''s recently released, next-generation PCT-based s ...


02.02.2017

Pressure BioSciences, Inc. to Present at RedChip''s Global Online Growth Conference

SOUTH EASTON, MA -- (Marketwired) -- 01/24/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO, is scheduled to present at RedChip''s Global Online Growth Conference on Wednesday January 25, 2017, at 1 ...


24.01.2017

Pressure BioSciences, Inc. to Present at the 2017 Biotech Showcase

SOUTH EASTON, MA -- (Marketwired) -- 01/10/17 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at the 9th Annual Biotech Showcase at 5pm PST on Tuesday, January 10, 2017. The B ...


10.01.2017

Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/16/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the third quarter ended September 30, 2016, and provided a business update.Products and services revenue increased to $500,949 for the third quarter of 2016 from $481,452 for the same quarter of 2015. This was a record high for products and services revenue in a quarter and marked the first time that products and services re ...


16.11.2016

Pressure BioSciences Announces Initial Close of $610,000 in $2.5 Million Private Placement

SOUTH EASTON, MA -- (Marketwired) -- 11/14/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure-based sample preparation solutions to the worldwide life sciences industry, led by their patented pressure cycling technology ("PCT") platform, today announced the initial close of $610,000 in gross proceeds in a $2.5 Million Private Placement (the "Financing"). Three accred ...


14.11.2016

Pressure BioSciences, Inc. to Discuss Third Quarter 2016 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 11/11/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2016 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay by telephone or on the Company''s website.The teleconference will include a Company presentation followed by ...


11.11.2016

Pressure BioSciences, Inc. Closes $2,000,000 Line-of-Credit

SOUTH EASTON, MA -- (Marketwired) -- 11/03/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling constant pressure and pressure cycling technology ("PCT")-based sample preparation solutions to the large and growing worldwide life sciences industry, today announced it has closed a $2 million line-of-credit with an accredited investor.On October 28, 2016, an accredited investor (the "In ...


03.11.2016

Pressure BioSciences'' PCT Platform Featured at Official Launch of Major Cancer Research Center Recently Chosen as a Collaborator in the US "Cancer Moonshot" Initiative

SOUTH EASTON, MA -- (Marketwired) -- 10/26/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling pressure cycling technology ("PCT")-based sample preparation solutions to the large and growing worldwide life sciences industry, today announced its featured participation in the recent opening of The ACRF International Centre for the Proteome of Human Cancer ("ProCan"), located in n ...


26.10.2016

Pressure BioSciences, Inc. Reports Second Quarter 2016 Financial Results and Provides Business Update

SOUTH EASTON, MA -- (Marketwired) -- 08/16/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO)Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the 2016 second quarter ended June 30, 2016, provided a business update, and offered limited guidance for the remainder of FY2016.Products and services revenue was $474,187 for the second quarter of 2016 compared to $333,575 for the same period in 2015, an increase of $140,612 or 42%. ...


16.08.2016

Pressure BioSciences, Inc. to Discuss Second Quarter 2016 Financial Results and Provide Business Update

SOUTH EASTON, MA -- (Marketwired) -- 08/15/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Second Quarter 2016 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay by telephone or on the Company''s website.The teleconference will include a Company presentation followed by ...


15.08.2016

StockNewsNow.com Publishes Q3 2015 Review SNNLive Video Interview With Pressure BioSciences, Inc.

LOS ANGELES, CA -- (Marketwired) -- 09/17/15 -- , The Official MicroCap News Source™, today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO). PBI is a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables used in the critical process of preparing samples for analysis in the estimated $6B life sciences research market, according to the Company'� ...


17.09.2015

Pressure BioSciences, Inc. Reports Strong First Quarter 2013 Financial Results

SOUTH EASTON, MA -- (Marketwired) -- 05/21/13 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three-month period ended March 31, 2013 and provided a business update.Total revenue for the first quarter of 2013 was $370,737 compared to $305,661 for the same period in 2012, a 21% increase. Revenue from the sale of pressure cycling technology ("PCT") products and services was $221,569 for the first quarter ...


21.05.2013

Pressure BioSciences, Inc. Reports Record PCT Product Sales in Q3 2012

SOUTH EASTON, MA -- (Marketwire) -- 11/15/12 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three and nine month periods ended September 30, 2012 and provided a business update.Total revenue for the third quarter of 2012 was $391,616 compared to $280,422 for the comparable period in 2011, a 40% increase. Revenue from the sale of Pressure Cycling Technology ("PCT") products and services was $297,867 for ...


15.11.2012

RocketAlerts.com Daily Winners: Titan Iron Ore Corp. (TFER) and Pressure BioSciences Inc. (PBIO). Get in, get out but don't stick around.

LAS VEGAS, NEVADA -- (Marketwire) -- 03/15/12 -- RocketAlerts highlights two Quick Buck opportunities of the day: Titan Iron Ore Corp. (TFER) and Pressure BioSciences Inc. (PBIO).At RocketAlerts we are keenly aware that even the most reliable hot stocks can suddenly change direction leaving some shareholders stranded in the vacuum of deep space. Our mission is to examine little known and often overlooked signs and events which point the way and supply our subscribers with the optimum entry and ...


15.03.2012

CEO of Pressure BioSciences Sees Firm's Momentum Continuing to Build in 2012

LOS ANGELES, CA -- (Marketwire) -- 02/27/12 -- In an exclusive video interview with BioMedReports', Richard T. Schumacher, the founder and Chief Executive Officer of Pressure BioSciences Inc. (NASDAQ: PBIO), tells investors about his firm, their science and the building momentum that has seen interest and volume in the stock rising in recent months.The life sciences company is ramping up the commercialization of their Pressure Cycling Technology (PCT), which offers the potential for broad ...


27.02.2012

Pressure BioSciences, Inc. Well Positioned to Play Important Role in US''s $1.8 Billion "Cancer Moonshot" Initiative

SOUTH EASTON, MA -- (Marketwired) -- 12/16/16 -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling pressure cycling technology ("PCT")-based sample preparation solutions to the large and growing worldwide life sciences industry, today discussed the potential impact on the Company of the $6.3 billion "21st Century Cures Act" that was signed into law earlier this week. The bill conta ...


16.12.2016



All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 47


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.